Literature DB >> 22775509

Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer.

L G Marcu1, E Bezak.   

Abstract

OBJECTIVES: Tumour re-population during radiotherapy was identified as an important reason for treatment failure in head and neck cancers. The process of re-population is suggested to be caused by various mechanisms, one of the most plausible one being accelerated division of stem-cells (i.e. drastic shortening of cell cycle duration). However, the literature lacks quantitative data regarding the length of tumour stem-cell cycle time during irradiation.
MATERIALS AND METHODS: The presented work suggests that if accelerated stem-cell division is indeed a key mechanism behind tumour re-population, the stem-cell cycle time can drop below 10 h during radiotherapy. To illustrate the possible implications, the mechanism of accelerated division was implemented into a Monte Carlo model of tumour growth and response to radiotherapy. Tumour response to radiotherapy was simulated with different stem-cell cycle times (between 2 and 10 h) after the initiation of radiotherapy.
RESULTS: It was found that very short stem-cell cycle times lead to tumour re-population during treatment, which cannot be overcome by radiation-induced cell kill. Increasing the number of radiation dose fractions per week might be effective, but only for longer cell cycle times.
CONCLUSION: It is of crucial importance to quantitatively assess the mechanisms responsible for tumour re-population, given that conventional treatment regimens are not efficient in delivering lethal doses to advanced head and neck tumours.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22775509      PMCID: PMC6496024          DOI: 10.1111/j.1365-2184.2012.00832.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  12 in total

Review 1.  The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation.

Authors:  K R Trott
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

2.  Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.

Authors:  W M Harriss-Phillips; E Bezak; E K Yeoh
Journal:  Br J Radiol       Date:  2011-10       Impact factor: 3.039

3.  Growth of a virtual tumour using probabilistic methods of cell generation.

Authors:  L Marcu; T van Doorn; S Zavgorodni; I Olver
Journal:  Australas Phys Eng Sci Med       Date:  2002-12       Impact factor: 1.430

4.  Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas.

Authors:  L Marcu; T van Doorn; I Olver
Journal:  Phys Med Biol       Date:  2004-08-21       Impact factor: 3.609

5.  Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues.

Authors:  K R Trott; J Kummermehr
Journal:  Radiother Oncol       Date:  1991-11       Impact factor: 6.280

6.  Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions.

Authors:  W Dörr
Journal:  Int J Radiat Biol       Date:  1997-12       Impact factor: 2.694

7.  Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG).

Authors:  J W Denham; Q J Walker; D S Lamb; C S Hamilton; P C O'Brien; N A Spry; A Hindley; M Poulsen; M O'Brien; L Tripcony
Journal:  Radiother Oncol       Date:  1996-11       Impact factor: 6.280

8.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 9.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Authors:  Jean Bourhis; Jens Overgaard; Hélène Audry; Kian K Ang; Michele Saunders; Jacques Bernier; Jean-Claude Horiot; Aurélie Le Maître; Thomas F Pajak; Michael G Poulsen; Brian O'Sullivan; Werner Dobrowsky; Andrzej Hliniak; Krzysztof Skladowski; John H Hay; Luiz H J Pinto; Carlo Fallai; Karen K Fu; Richard Sylvester; Jean-Pierre Pignon
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

10.  The hazard of accelerated tumor clonogen repopulation during radiotherapy.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

View more
  4 in total

1.  Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients.

Authors:  Nai-Wen Su; Chung-Ji Liu; Yi-Shing Leu; Jehn-Chuan Lee; Yu-Jen Chen; Yi-Fang Chang
Journal:  Onco Targets Ther       Date:  2015-01-28       Impact factor: 4.147

2.  Radiobiologically derived biphasic fractionation schemes to overcome the effects of tumour hypoxia.

Authors:  Nuradh Joseph; Norman F Kirkby; Peter J Hoskin; Catharine M L West; Ananya Choudhury; Roger G Dale
Journal:  Br J Radiol       Date:  2020-06-02       Impact factor: 3.039

3.  BlueBerry Isolate, Pterostilbene, Functions as a Potential Anticancer Stem Cell Agent in Suppressing Irradiation-Mediated Enrichment of Hepatoma Stem Cells.

Authors:  Chi-Ming Lee; Yen-Hao Su; Thanh-Tuan Huynh; Wei-Hwa Lee; Jeng-Fong Chiou; Yen-Kuang Lin; Michael Hsiao; Chih-Hsiung Wu; Yuh-Feng Lin; Alexander T H Wu; Chi-Tai Yeh
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

4.  Clinical effectiveness, toxicity, and failure patterns of helical tomotherapy for postoperative oral cavity cancer patients.

Authors:  Chen-Hsi Hsieh; Pei-Wei Shueng; Li-Ying Wang; Li-Jen Liao; Yu-Chin Lin; Ying-Shiung Kuo; Wu-Chia Lo; Chien-Fu Tseng; Hui-Ju Tien; Hsiu-Ling Chou; Yen-Ping Hsieh; Le-Jung Wu; Yu-Jen Chen
Journal:  Onco Targets Ther       Date:  2014-03-10       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.